Crossmark

Hepatic focal nodular hyperplasia during follow-up of patients after cyclophosphamide- or oxaliplatin-based chemotherapy: differentiation from liver metastasis

Crossref DOI link: https://doi.org/10.1186/s13244-024-01793-7

Published Online: 2024-08-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Fan

Peng, Wenjing

Chen, Shuang

Wan, Lijuan

Zhao, Rui

Liu, Xiangchun

Ye, Feng

Zhang, Hongmei http://orcid.org/0000-0002-6421-4126
License Information

Text and Data Mining valid from 2024-08-26

Version of Record valid from 2024-08-26
More Information

Article History

Received: 23 April 2024

Accepted: 2 August 2024

First Online: 26 August 2024

Declarations

:

: This study was approved by the ethics committee of our hospital, and owing to this study’s retrospective nature, the requirement for informed consent was waived.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below